An immunotherapy kept multiple myeloma at bay for over 80 percent of patients in a three-year clinical trial, and the FDA ...
Dr. James C. Wittig, one of the world's top orthopedic oncologists, led a team of residents and innovators in 2024 to successfully implement a surgical solution for an exceedingly rare orthopedic ...
Enoby and Xtrenbo are FDA-approved biosimilars for denosumab, providing cost-effective alternatives to Prolia and Xgeva for cancer patients. Enoby targets bone loss in patients on hormone-based ...
Researchers from UC Davis and Lawrence Livermore National Laboratory developed and studied a new material — engineered bone marrow, or eBM. Engineered bone marrow offers a better way to study ...
Even though I have a degree in biology, I knew little about cancer – until life gave me a crash course. In 2019, while working on my master’s degree in Huntsville, I developed severe leg pain. At ...